These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 9552176)

  • 1. Blockade of the reward-potentiating effects of nicotine on lateral hypothalamic brain stimulation by chlorisondamine.
    Wise R; Marcangione C; Bauco P
    Synapse; 1998 May; 29(1):72-9. PubMed ID: 9552176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of methyllycaconitine (MLA), an alpha 7 nicotinic receptor antagonist, on nicotine- and cocaine-induced potentiation of brain stimulation reward.
    Panagis G; Kastellakis A; Spyraki C; Nomikos G
    Psychopharmacology (Berl); 2000 May; 149(4):388-96. PubMed ID: 10867966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reward and somatic changes during precipitated nicotine withdrawal in rats: centrally and peripherally mediated effects.
    Watkins SS; Stinus L; Koob GF; Markou A
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1053-64. PubMed ID: 10688623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent nicotinic blockade by chlorisondamine of noradrenergic neurons in rat brain and cultured PC12 cells.
    Reuben M; Louis M; Clarke PB
    Br J Pharmacol; 1998 Nov; 125(6):1218-27. PubMed ID: 9863650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of nicotine and chlorisondamine on cerebral glucose utilization in immobilized and freely-moving rats.
    Marenco T; Bernstein S; Cumming P; Clarke PB
    Br J Pharmacol; 2000 Jan; 129(1):147-55. PubMed ID: 10694214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of lateral hypothalamic and midline mesencephalic brain stimulation reinforcement by nicotine: examination of repeated treatment.
    Bauco P; Wise RA
    J Pharmacol Exp Ther; 1994 Oct; 271(1):294-301. PubMed ID: 7965727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic central nicotinic blockade after a single administration of the bisquaternary ganglion-blocking drug chlorisondamine.
    Clarke PB
    Br J Pharmacol; 1984 Oct; 83(2):527-35. PubMed ID: 6148986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacology of the nicotinic antagonist, chlorisondamine, investigated in rat brain and autonomic ganglion.
    Clarke PB; Chaudieu I; el-Bizri H; Boksa P; Quik M; Esplin BA; Capek R
    Br J Pharmacol; 1994 Feb; 111(2):397-405. PubMed ID: 7911713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular effects of nicotine, chlorisondamine, and mecamylamine in the pigeon.
    Chadman KK; Woods JH
    J Pharmacol Exp Ther; 2004 Jan; 308(1):73-8. PubMed ID: 14566012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlorisondamine inhibits the nicotine-induced stimulation of c-fos in the pigeon brain for up to 2 weeks.
    Chadman KK; Woods JH; Stitzel J
    Nicotine Tob Res; 2007 Sep; 9(9):927-36. PubMed ID: 17763108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rat brain CYP2B induction by nicotine is persistent and does not involve nicotinic acetylcholine receptors.
    Khokhar JY; Miksys SL; Tyndale RF
    Brain Res; 2010 Aug; 1348():1-9. PubMed ID: 20599831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addictive drugs and brain stimulation reward.
    Wise RA
    Annu Rev Neurosci; 1996; 19():319-40. PubMed ID: 8833446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain stimulation and morphine reward deficits in dopamine D2 receptor-deficient mice.
    Elmer GI; Pieper JO; Levy J; Rubinstein M; Low MJ; Grandy DK; Wise RA
    Psychopharmacology (Berl); 2005 Oct; 182(1):33-44. PubMed ID: 16136297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rewarding stimulation of the lateral hypothalamus induces a dopamine-dependent suppression of synaptic responses in the entorhinal cortex.
    Hutter JA; Martel A; Trigiani L; Barrett SG; Chapman CA
    Behav Brain Res; 2013 Sep; 252():266-74. PubMed ID: 23747609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic nicotine exposure switches the functional role of mesolimbic dopamine transmission in the processing of nicotine's rewarding and aversive effects.
    Tan H; Bishop SF; Lauzon NM; Sun N; Laviolette SR
    Neuropharmacology; 2009 Mar; 56(4):741-51. PubMed ID: 19133278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ghrelin receptor antagonism attenuates nicotine-induced locomotor stimulation, accumbal dopamine release and conditioned place preference in mice.
    Jerlhag E; Engel JA
    Drug Alcohol Depend; 2011 Sep; 117(2-3):126-31. PubMed ID: 21310553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic nicotine and dizocilpine effects on regionally specific nicotinic and NMDA glutamate receptor binding.
    Levin ED; Tizabi Y; Rezvani AH; Caldwell DP; Petro A; Getachew B
    Brain Res; 2005 Apr; 1041(2):132-42. PubMed ID: 15829222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of mesolimbic dopamine transmission dramatically increases sensitivity to the rewarding effects of nicotine in the ventral tegmental area.
    Laviolette SR; van der Kooy D
    Mol Psychiatry; 2003 Jan; 8(1):50-9, 9. PubMed ID: 12556908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotine-activated descending facilitation on spinal NMDA-dependent reflex potentiation from pontine tegmentum in rats.
    Pan SF; Peng HY; Chen CC; Chen MJ; Lee SD; Cheng CL; Shyu JC; Liao JM; Chen GD; Lin TB
    Am J Physiol Renal Physiol; 2008 May; 294(5):F1195-204. PubMed ID: 18287401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of atropine, procaine and dopamine in the rat ventral tegmentum on lateral hypothalamic rewarding brain stimulation.
    Kofman O; McGlynn SM; Olmstead MC; Yeomans JS
    Behav Brain Res; 1990 Apr; 38(1):55-68. PubMed ID: 2346616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.